Potential treatment for Parkinson’s dementia

A potential drug treatment for Parkinson’s dementia called ENT-01 improved cognitive function in some trial participants.  During the 10-week treatment period these participants had better mental abilities such as remembering and problem-solving, and these continued to improve during the six weeks following treatment.  The charity Parkinson’s UK has invested £2 million in phase 2 of the clinical trial, led by US biotech company Enterin.  “While Parkinson’s is more commonly associated with motor symptoms like tremor, our community has asked us to make new and better treatments for Parkinson’s dementia a priority,” said Parkinson’s UK director of research Arthur Roach.  “We are encouraged by the clinical results that Enterin’s work has produced to date and look forward to the upcoming clinical trial which will have sites in the UK as well as in America.”

Similar Posts

  • The Dysphagia Guide – Updated for 2024 

    elearning for Healthcare, in partnership with NHS England, has shared an updated learning resource to support knowledge and understanding of the management of dysphagia.  The Dysphagia Guide e-learning resource has been co-developed with care home staff but is also relevant to other health and social care staff, informal carers and people with dysphagia. The Guide…

  • Major Conditions Strategy

    Health secretary Steve Barclay held out the prospect of a government Major Conditions Strategy designed to tackle six health conditions including dementia. Barclay told the House of Commons that the policy would mark a shift to “integrated, whole-person care,” alleviating pressure on the health system, increasing healthy life expectancy and reducing health-related unemployment. The major…

  • Blood biomarker challenge

    Dementia blood tests could be available on the NHS in five years, Alzheimer’s Society claims, after launching the next phase of its Blood Biomarker Challenge, a £5 million award for the research team judged most likely to deliver. Applications for the challenge, a collaboration with Alzheimer’s Research UK and the National Institute for Health and…

  • Royally treated

    Professor Dawn Brooker received her MBE, awarded in the 2021 New Year’s Honours, at Windsor Castle last week.  Princess Anne took charge of the MBE investiture, where Dawn reports that the princess was “very happy talking about dementia”.  Dawn is director of the Association of Dementia Studies, University of Worcester, and a long-standing member of…